Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial

Overview of attention for article published in Cancer Management and Research, May 2019

Altmetric Badge

Mentioned by

reddit: 1 Redditor

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 15 Mendeley

Summary Reddit Dimensions citations

So far, Altmetric has seen 1 Reddit thread.

Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial

User montaukwhaler, in the non small cell lung cancer subreddit, 13 May 2019